FDA Warns Pharma about Facebook Shares
Written by Ann Pietrangelo on August 9th, 2010 in Health Care Policy, In The News, Linked Articles.
Pharmaceuticals promoting their products through Facebook “Shares” have been warned by the U.S. Food and Drug Administration (FDA)… and they’re apparently heeding that warning.
Pharmaceutical company Novartis removed it’s Facebook Share after receiving a letter from the FDA warning that the Facebook Share button it is using to promote its cancer medication, Tasigna, violates FDA requirements about disclosure of drug information, and that the information is misleading and “implies superiority over other product.”
Read the article:
FDA Warns Pharma about Facebook Shares
Photo: photoxpress.com
